A citation-based method for searching scientific literature

Guoli Shi, Adam D Kenney, Elena Kudryashova, Lizhi Zhang, Luanne Hall-Stoodley, Richard T Robinson, Dmitri S Kudryashov, Alex A Compton, Jacob S Yount. bioRxiv 2020
Times Cited: 9







List of co-cited articles
65 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus.
I-Chueh Huang, Charles C Bailey, Jessica L Weyer, Sheli R Radoshitzky, Michelle M Becker, Jessica J Chiang, Abraham L Brass, Asim A Ahmed, Xiaoli Chi, Lian Dong,[...]. PLoS Pathog 2011
415
66

Opposing activities of IFITM proteins in SARS-CoV-2 infection.
Guoli Shi, Adam D Kenney, Elena Kudryashova, Ashley Zani, Lizhi Zhang, Kin Kui Lai, Luanne Hall-Stoodley, Richard T Robinson, Dmitri S Kudryashov, Alex A Compton,[...]. EMBO J 2021
72
66

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, Tobias S Schiergens, Georg Herrler, Nai-Huei Wu, Andreas Nitsche,[...]. Cell 2020
55

Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses.
Xuesen Zhao, Mohit Sehgal, Zhifei Hou, Junjun Cheng, Sainan Shu, Shuo Wu, Fang Guo, Sylvain J Le Marchand, Hanxin Lin, Jinhong Chang,[...]. J Virol 2018
61
55

Interferon induction of IFITM proteins promotes infection by human coronavirus OC43.
Xuesen Zhao, Fang Guo, Fei Liu, Andrea Cuconati, Jinhong Chang, Timothy M Block, Ju-Tao Guo. Proc Natl Acad Sci U S A 2014
109
44

The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus.
Abraham L Brass, I-Chueh Huang, Yair Benita, Sinu P John, Manoj N Krishnan, Eric M Feeley, Bethany J Ryan, Jessica L Weyer, Louise van der Weyden, Erol Fikrig,[...]. Cell 2009
896
44

IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread.
Alex A Compton, Timothée Bruel, Françoise Porrot, Adeline Mallet, Martin Sachse, Marine Euvrard, Chen Liang, Nicoletta Casartelli, Olivier Schwartz. Cell Host Microbe 2014
127
33

Syncytia formation by SARS-CoV-2-infected cells.
Julian Buchrieser, Jérémy Dufloo, Mathieu Hubert, Blandine Monel, Delphine Planas, Maaran Michael Rajah, Cyril Planchais, Françoise Porrot, Florence Guivel-Benhassine, Sylvie Van der Werf,[...]. EMBO J 2020
154
33


Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.
Daniel Blanco-Melo, Benjamin E Nilsson-Payant, Wen-Chun Liu, Skyler Uhl, Daisy Hoagland, Rasmus Møller, Tristan X Jordan, Kohei Oishi, Maryline Panis, David Sachs,[...]. Cell 2020
33

Bat SARS-Like WIV1 coronavirus uses the ACE2 of multiple animal species as receptor and evades IFITM3 restriction via TMPRSS2 activation of membrane fusion.
Mei Zheng, Xuesen Zhao, Shuangli Zheng, Danying Chen, Pengcheng Du, Xinglin Li, Dong Jiang, Ju-Tao Guo, Hui Zeng, Hanxin Lin. Emerg Microbes Infect 2020
26
33

IFITM proteins restrict viral membrane hemifusion.
Kun Li, Ruben M Markosyan, Yi-Min Zheng, Ottavia Golfetto, Brittani Bungart, Minghua Li, Shilei Ding, Yuxian He, Chen Liang, James C Lee,[...]. PLoS Pathog 2013
234
33

IFITM3 inhibits influenza A virus infection by preventing cytosolic entry.
Eric M Feeley, Jennifer S Sims, Sinu P John, Christopher R Chin, Thomas Pertel, Li-Mei Chen, Gaurav D Gaiha, Bethany J Ryan, Ruben O Donis, Stephen J Elledge,[...]. PLoS Pathog 2011
265
33

IFITM3 directly engages and shuttles incoming virus particles to lysosomes.
Jennifer S Spence, Ruina He, Hans-Heinrich Hoffmann, Tandrila Das, Emmanuelle Thinon, Charles M Rice, Tao Peng, Kartik Chandran, Howard C Hang. Nat Chem Biol 2019
109
33

IFITM Genes, Variants, and Their Roles in the Control and Pathogenesis of Viral Infections.
Xuesen Zhao, Jiarui Li, Cheryl A Winkler, Ping An, Ju-Tao Guo. Front Microbiol 2019
65
33

Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells.
Shutoku Matsuyama, Naganori Nao, Kazuya Shirato, Miyuki Kawase, Shinji Saito, Ikuyo Takayama, Noriyo Nagata, Tsuyoshi Sekizuka, Hiroshi Katoh, Fumihiro Kato,[...]. Proc Natl Acad Sci U S A 2020
695
22

The antiviral restriction factors IFITM1, 2 and 3 do not inhibit infection of human papillomavirus, cytomegalovirus and adenovirus.
Cody J Warren, Laura M Griffin, Alexander S Little, I-Chueh Huang, Michael Farzan, Dohun Pyeon. PLoS One 2014
53
22


Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.
Alexandra C Walls, Young-Jun Park, M Alejandra Tortorici, Abigail Wall, Andrew T McGuire, David Veesler. Cell 2020
22

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Chaolin Huang, Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, Li Zhang, Guohui Fan, Jiuyang Xu, Xiaoying Gu,[...]. Lancet 2020
22

LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
Xuesen Zhao, Shuangli Zheng, Danying Chen, Mei Zheng, Xinglin Li, Guoli Li, Hanxin Lin, Jinhong Chang, Hui Zeng, Ju-Tao Guo. J Virol 2020
42
22


LY6E impairs coronavirus fusion and confers immune control of viral disease.
Stephanie Pfaender, Katrina B Mar, Eleftherios Michailidis, Annika Kratzel, Ian N Boys, Philip V'kovski, Wenchun Fan, Jenna N Kelly, Dagny Hirt, Nadine Ebert,[...]. Nat Microbiol 2020
99
22


SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology.
Natacha S Ogando, Tim J Dalebout, Jessika C Zevenhoven-Dobbe, Ronald W A L Limpens, Yvonne van der Meer, Leon Caly, Julian Druce, Jutte J C de Vries, Marjolein Kikkert, Montserrat Bárcena,[...]. J Gen Virol 2020
236
22

Type III interferons disrupt the lung epithelial barrier upon viral recognition.
Achille Broggi, Sreya Ghosh, Benedetta Sposito, Roberto Spreafico, Fabio Balzarini, Antonino Lo Cascio, Nicola Clementi, Maria De Santis, Nicasio Mancini, Francesca Granucci,[...]. Science 2020
183
22

TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium.
Stephanie Bertram, Ronald Dijkman, Matthias Habjan, Adeline Heurich, Stefanie Gierer, Ilona Glowacka, Kathrin Welsch, Michael Winkler, Heike Schneider, Heike Hofmann-Winkler,[...]. J Virol 2013
185
22

Type I and III interferons disrupt lung epithelial repair during recovery from viral infection.
Jack Major, Stefania Crotta, Miriam Llorian, Teresa M McCabe, Hans Henrik Gad, Simon L Priestnall, Rune Hartmann, Andreas Wack. Science 2020
166
22

Antiviral Protection by IFITM3 In Vivo.
Ashley Zani, Jacob S Yount. Curr Clin Microbiol Rep 2018
46
22

A pneumonia outbreak associated with a new coronavirus of probable bat origin.
Peng Zhou, Xing-Lou Yang, Xian-Guang Wang, Ben Hu, Lei Zhang, Wei Zhang, Hao-Rui Si, Yan Zhu, Bei Li, Chao-Lin Huang,[...]. Nature 2020
22

Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2.
Yuan-Lin Kang, Yi-Ying Chou, Paul W Rothlauf, Zhuoming Liu, Timothy K Soh, David Cureton, James Brett Case, Rita E Chen, Michael S Diamond, Sean P J Whelan,[...]. Proc Natl Acad Sci U S A 2020
93
22

Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells.
Megan L Stanifer, Carmon Kee, Mirko Cortese, Camila Metz Zumaran, Sergio Triana, Markus Mukenhirn, Hans-Georg Kraeusslich, Theodore Alexandrov, Ralf Bartenschlager, Steeve Boulant. Cell Rep 2020
177
22

Interferon-Stimulated Genes: What Do They All Do?
John W Schoggins. Annu Rev Virol 2019
248
22

SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes.
Waradon Sungnak, Ni Huang, Christophe Bécavin, Marijn Berg, Rachel Queen, Monika Litvinukova, Carlos Talavera-López, Henrike Maatz, Daniel Reichart, Fotios Sampaziotis,[...]. Nat Med 2020
22

A diverse range of gene products are effectors of the type I interferon antiviral response.
John W Schoggins, Sam J Wilson, Maryline Panis, Mary Y Murphy, Christopher T Jones, Paul Bieniasz, Charles M Rice. Nature 2011
22

A new coronavirus associated with human respiratory disease in China.
Fan Wu, Su Zhao, Bin Yu, Yan-Mei Chen, Wen Wang, Zhi-Gang Song, Yi Hu, Zhao-Wu Tao, Jun-Hua Tian, Yuan-Yuan Pei,[...]. Nature 2020
22

Natural mutations in IFITM3 modulate post-translational regulation and toggle antiviral specificity.
Alex A Compton, Nicolas Roy, Françoise Porrot, Anne Billet, Nicoletta Casartelli, Jacob S Yount, Chen Liang, Olivier Schwartz. EMBO Rep 2016
64
22

IFITM3: How genetics influence influenza infection demographically.
Dannielle Wellington, Henry Laurenson-Schafer, Adi Abdel-Haq, Tao Dong. Biomed J 2019
25
22

Interferon-Induced Transmembrane Protein (IFITM3) Is Upregulated Explicitly in SARS-CoV-2 Infected Lung Epithelial Cells.
Mahmood Yaseen Hachim, Saba Al Heialy, Ibrahim Yaseen Hachim, Rabih Halwani, Abiola C Senok, Azzam A Maghazachi, Qutayba Hamid. Front Immunol 2020
33
22

IFITM3 restricts the morbidity and mortality associated with influenza.
Aaron R Everitt, Simon Clare, Thomas Pertel, Sinu P John, Rachael S Wash, Sarah E Smith, Christopher R Chin, Eric M Feeley, Jennifer S Sims, David J Adams,[...]. Nature 2012
517
22

Interferon-Induced Transmembrane Protein 3 Genetic Variant rs12252-C Associated With Disease Severity in Coronavirus Disease 2019.
Yonghong Zhang, Ling Qin, Yan Zhao, Ping Zhang, Bin Xu, Kang Li, Lianchun Liang, Chi Zhang, Yanchao Dai, Yingmei Feng,[...]. J Infect Dis 2020
80
22

Human cytomegalovirus exploits interferon-induced transmembrane proteins to facilitate morphogenesis of the virion assembly compartment.
Maorong Xie, Baoqin Xuan, Jiaoyu Shan, Deng Pan, Yamei Sun, Zhao Shan, Jinping Zhang, Dong Yu, Bin Li, Zhikang Qian. J Virol 2015
41
22

IFITM proteins inhibit HIV-1 protein synthesis.
Wing-Yiu Jason Lee, Rebecca Menhua Fu, Chen Liang, Richard D Sloan. Sci Rep 2018
25
22

The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry.
Samad Amini-Bavil-Olyaee, Youn Jung Choi, Jun Han Lee, Mude Shi, I-Chueh Huang, Michael Farzan, Jae U Jung. Cell Host Microbe 2013
221
22

The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication.
Sinu P John, Christopher R Chin, Jill M Perreira, Eric M Feeley, Aaron M Aker, George Savidis, Sarah E Smith, Andrew E H Elia, Aaron R Everitt, Mehul Vora,[...]. J Virol 2013
123
22

Interferon-induced transmembrane protein 3 blocks fusion of sensitive but not resistant viruses by partitioning into virus-carrying endosomes.
Krishna C Suddala, Christine C Lee, Paul Meraner, Mariana Marin, Ruben M Markosyan, Tanay M Desai, Fredric S Cohen, Abraham L Brass, Gregory B Melikyan. PLoS Pathog 2019
39
22

IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus.
Rajini Mudhasani, Julie P Tran, Cary Retterer, Sheli R Radoshitzky, Krishna P Kota, Louis A Altamura, Jeffrey M Smith, Beverly Z Packard, Jens H Kuhn, Julie Costantino,[...]. J Virol 2013
87
22

The IFITMs Inhibit Zika Virus Replication.
George Savidis, Jill M Perreira, Jocelyn M Portmann, Paul Meraner, Zhiru Guo, Sharone Green, Abraham L Brass. Cell Rep 2016
139
22

Interferon-Induced Transmembrane Protein-Mediated Inhibition of Host Cell Entry of Ebolaviruses.
Florian Wrensch, Christina B Karsten, Kerstin Gnirß, Markus Hoffmann, Kai Lu, Ayato Takada, Michael Winkler, Graham Simmons, Stefan Pöhlmann. J Infect Dis 2015
41
22

Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction.
Toshana L Foster, Harry Wilson, Shilpa S Iyer, Karen Coss, Katie Doores, Sarah Smith, Paul Kellam, Andrés Finzi, Persephone Borrow, Beatrice H Hahn,[...]. Cell Host Microbe 2016
109
22


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.